About NeoCura

Founded in Aug. 2017, NeoCura Bio-Medical Technology Co., Ltd. (NeoCura for short) is committed to building a global  leading RNA innovative drug platform. It has built  multi-omics big data collection  platform and  multi-biomics database to perform in-depth drug target mining and fully automated drug design based on AI algorithm and core bioinformatic technologies. Through application in clinical innovative RNA drug development and next-generation, safe, and efficient clinical precision diagnosis and treatment, NeoCura provides patients with one-stop full-cycle solution  from screening, diagnosis, treatment to efficacy monitoring.



Technical Superiority

Team 

Advantage

AI algorithm + real-world data validation facilitates  clinical research of RNA drugs and fully automated drug design based on AI algorithm and core bioinformatic technologies

NeoCura has applied for more than 30 patents of inventions in China and more than 10 patents of inventions abroad based on its core technologies;

Hundreds of articles published in Nature, Science, Cell, Nature Methods, Immunity, and other global top journals;

Research Strengths

Academic Achievements

ABOUT US

The R&D team consists of dozens 

of doctors/post-doctors from prestigious schools such as Harvard University, Cornell University, Tsinghua University, Peking University, and Chinese Academy of Sciences;

03

NeoCura   

02

NeoCura   

01

NeoCura   

R&D Pipelines

TM

TM

TM

Cancer Neoantigen Vaccines

Tumor Microenvironment Immuno-Modulators

Virus vaccine

Ag

IM

PV

Science Platforms

News

News
More
  • NeoCura and PhoreMos

    NeoCura and PhoreMos

    Jointly Develop Innovative Therapies for Cancer Treatment

  • Official Announcemen

    Official Announcemen

    Advance the research and development progress of pipelineoptimize the AI (artificial intelligence) platform

  • NeoCura and INT Anno

    NeoCura and INT Anno

    This strategic collaboration adds to the ever-growing armamentarium of NeoCura in delivering mRNA drugs more efficiently, effectively and specifically.

  • NeoCura and Innovent

    NeoCura and Innovent

    This cooperation is expected to improve the objective remission rate of tumor immunotherapy and bring new inspiration to the combined treatment scheme of tumor.

News Center

Research News

Scan code to follow us on WeChat

NeoCura Bio-Medical Technology Co., Ltd.

Beijing: Floor 2, Building 1, 29 Shengmingyuan Road, Life Science Park, Changping District, Beijing





  • Ʒ
  • ̳
  • Ƶ
Search

Websitewww.neocura.com.cn

E-mailinfo@neocura.net

Tel+86 10 80766127




Guangzhou: Floor 10, Tower B, 388 Lianyun Road, Huangpu District, Guangzhou





Shenzhen: Floor 4, Building B50, Zhongchuang Industrial Park, Nanshan District, Shenzhen

Address:

  • Telephone

    • 010-80766127
  • ΢ɨһɨ